GE HealthCare Technologies Inc.

09/27/2024 | Press release | Distributed by Public on 09/27/2024 15:17

GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease